Doximity (DOCS) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 May, 2026Market position and platform reach
Over 85% of U.S. physicians are members, with more than 800,000 unique active providers using workflow tools as of Q1 2026.
Serves all top 20 U.S. hospitals and pharmaceutical manufacturers, demonstrating strong industry penetration.
Net revenue retention rate stands at 109%, indicating high customer loyalty and expansion.
Product innovation and engagement
Offers a comprehensive suite of HIPAA-compliant tools, including telehealth, digital fax, e-signature, secure messaging, and AI-powered workflow solutions.
Clinical AI suite features tools like Scribe and Ask, providing private, real-time support for clinicians.
Engagement is strong throughout the day, with over 1 million unique quarterly active prescribers.
AI-powered search and clinical reference tools enhance point-of-care decision-making.
Commercial solutions and revenue model
Marketing solutions are the largest revenue driver, offering personalized, subscription-based packages for pharma and health systems.
Delivers a median ROI of 17:1 for health systems and 10:1 for pharma clients, based on third-party data.
Land-and-expand sales strategy increases module adoption across brands and service lines.
Dynamic integrated offering leverages proprietary and third-party data for higher quality engagements and measurable HCP behavior change.
Latest events from Doximity
- Record free cash flow, robust AI adoption, and strong revenue growth with a positive outlook.DOCS
Q4 202613 May 2026 - Revenue up 10% to $185.1M, strong margins, AI acquisition, and $500M buyback authorized.DOCS
Q3 202616 Apr 2026 - AI-powered platform with 85% physician reach, rapid revenue growth, and strong market penetration.DOCS
Investor presentation25 Feb 2026 - Revenue up 17% to $126.7M, profits and margins rose, and FY25 guidance was raised.DOCS
Q1 20251 Feb 2026 - Q2 revenue up 20% to $137M, net income up 44%, and margins hit records on strong platform growth.DOCS
Q2 202515 Jan 2026 - Q3 revenue up 25%, net income up 57%, and margins strong amid robust platform engagement.DOCS
Q3 20258 Jan 2026 - Proxy covers director elections, auditor ratification, pay, governance, and ESG priorities.DOCS
Proxy Filing1 Dec 2025 - Board recommends approving director nominees, auditor, and executive pay, with strong governance and ESG focus.DOCS
Proxy Filing1 Dec 2025 - Virtual meeting on August 29, 2024, covers director elections, auditor ratification, and say-on-pay.DOCS
Proxy Filing1 Dec 2025